CIK 0001815776 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
LENZ Therapeutics, Inc.
Sign in to watch- Ticker
- LENZ
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 844867570
- Phone
- 858-925-7000
- Business address
- 201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH, CA, 92075
- Former names
- Graphite Bio, Inc.
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Material agreement · Unregistered share sale · Regulation FD disclosure
- 8-K Event Results of operations
- 8-K Event Other events
- 8-K Event Acquisition or sale completed · Unregistered share sale · Shareholder rights changed · Auditor change · Change in control · Executive or director change · Bylaws or fiscal year change · Code of ethics change · Shell status change · Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 8-K Event Shareholder vote results
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 10-K Report Annual Report
- 8-K Event Other events
- 8-K Event Material agreement · Unregistered share sale · Change in control · Executive or director change · Regulation FD disclosure
- 8-K Event Material agreement
- 8-K/A Event Executive or director change
- 8-K Event Exit or restructuring costs · Executive or director change · Other events
Page 2 of 4 · 70 filings